Sutro Biopharma Appoints Sukhi Jagpal to Board and Audit Committee
Company Announcements

Sutro Biopharma Appoints Sukhi Jagpal to Board and Audit Committee

Sutro Biopharma (STRO) has provided an announcement.

Sutro Biopharma, Inc. has appointed Sukhi Jagpal as a Class III director and member of the Audit Committee, with his directorship beginning on August 8, 2024, and committee membership starting on August 15, 2024. As part of his compensation, Jagpal will receive prorated annual retainers and stock options vesting over three years and until the 2025 annual meeting, respectively, provided he continues his service with the company. This appointment involves no familial ties or material interests in company transactions that would necessitate disclosure.

Learn more about STRO stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlySutro Biopharma initiates REFRaME-P1 trial of luvelta in AML
TheFlySutro Biopharma management to meet with Truist
TheFlySutro announces data from Phase 1b study of Luvelta in combo with Bevacizumab
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App